Adrenoleukodystrophy: Clinical Trials

3 trials for Adrenoleukodystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 12Terminated 2

Follow Adrenoleukodystrophy: new trials by email Literature Review of Adrenoleukodystrophy trials Research Report on Adrenoleukodystrophy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)
SBT101 Treatment - AMN, AMN Gene Mutation
Phase 1 / Phase 2TerminatedSwanBio Therapeutics, Inc.92022-11-172026-08-26
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
glyceryl trierucate/glyceryl trioleate - Adrenoleukodystrophy
Phase 2TerminatedHugo W. Moser Research Institute at Kennedy Krieger, Inc.1261998-04-012020-10-23

Narrower conditions

Metabolism, Inborn Errors (2)  ·  Adrenal Insufficiency (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Demyelinating Diseases (1)  ·  Hereditary Central Nervous System Demyelinating Diseases (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Leukoencephalopathies (1)  ·  Metabolic Diseases (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)  ·  Mucopolysaccharidosis III (1)

Broader conditions

Adrenal Gland Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Endocrine System Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Genetic Diseases, X-Linked (3)  ·  Intellectual Disability (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  X-Linked Intellectual Disability (3)  ·  Adrenal Insufficiency (2)

Interventions

Lorenzo's oil (1)  ·  Stem Cell Transplantation (1)  ·  Triolein (1)  ·  trierucate (1)

Sponsors

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)  ·  SwanBio Therapeutics, Inc. (1)  ·  Talaris Therapeutics Inc. (1)

Countries

United States (3)  ·  Netherlands (1)

Top investigators

Gerald V Raymond, M.D. (1)  ·  Suzanne T Ildstad, MD (1)